{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T10:57:24Z","timestamp":1794653844657,"version":"4.9.1"},"reference-count":43,"publisher":"BMJ","issue":"9","license":[{"start":{"date-parts":[[2025,9,4]],"date-time":"2025-09-04T00:00:00Z","timestamp":1756944000000},"content-version":"unspecified","delay-in-days":3,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000740","name":"University of St Andrews","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000740","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open"],"accepted":{"date-parts":[[2025,8,20]]},"published-print":{"date-parts":[[2025,9]]},"abstract":"<jats:sec>\n                  <jats:title>Objectives<\/jats:title>\n                  <jats:p>To describe: (1) the most visible information (from individuals or organisations) on UK social media regarding hormone replacement therapy (HRT)\/menopause hormone treatment for menopause; (2) claims made by these sources for HRT and testosterone outwith the indications specified by the British National Formulary (BNF) and the National Institute of Health and Care Excellence (NICE) (ie, vasomotor instability, vaginal dryness, low mood associated with the menopause and, for testosterone, low libido after treatment with HRT) and for use for the prevention of future ill health and (3) conflicts of interest of commentators.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Design<\/jats:title>\n                  <jats:p>Cross-sectional study.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Setting<\/jats:title>\n                  <jats:p>Online references to HRT, for use in menopause, in UK online media, comprising Facebook, Google, Instagram, TikTok and YouTube, 30 top ranked hits between 1 January 2022 and 1 June 2023 and Twitter (X) up to 1 May 2024.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>Identification of the most visible information was performed via online searching with the term \u2018HRT\u2019 using incognito searches within each modality. Statements making claims were identified and analysed as to whether they were congruent with BNF and NICE advice on indications for use. Declarations of interest were extracted from the source or searched for if not apparent using a standardised search strategy. Data were entered into an Excel spreadsheet. Summary and descriptive statistics were used to summarise the results, including description of origin and types of claims, percentage of claims in agreement with NICE\/BNF indications, relationship to financial interests and readership data, where available.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>180 recommendations and\/or claims for HRT were examined (30 from each of six platforms), made by professional individuals (53.4%), laypeople (41.7%) and patient, media and professional organisations (4.9%) completing the total. Overall, 67.2% of claims were outside of BNF\/NICE recommendations. 139 (77.2%) were associated with a conflict of interest. In 117 cases, this was a conflict either directly or indirectly related to menopause, through provision of private practice, pharmaceutical industry funding or retail products marketed at the menopause.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>Social media commonly contains claims for HRT outside BNF\/NICE guidance. Conflicts of interest by commentators are also common, directly or indirectly related to menopause. Less than a quarter of media contained no commercial conflict. Policymakers should consider means to ensure that non-conflicted, evidence-based information is visible to professionals, patients and the public.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Trial registration number<\/jats:title>\n                  <jats:p>Open Science Framework (<jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/osf.io\/r7e5c\/\">https:\/\/osf.io\/r7e5c\/<\/jats:ext-link>).<\/jats:p>\n               <\/jats:sec>","DOI":"10.1136\/bmjopen-2024-094773","type":"journal-article","created":{"date-parts":[[2025,9,4]],"date-time":"2025-09-04T15:21:35Z","timestamp":1756999295000},"page":"e094773","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":8,"title":["Does online information about hormone replacement therapy (or menopause hormone therapy) reflect indications from the British National Formulary and guidance from the National Institute for Health and Care Excellence: a cross-sectional study of UK media"],"prefix":"10.1136","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7238-6358","authenticated-orcid":false,"given":"Margaret","family":"McCartney","sequence":"first","affiliation":[{"name":"University of St Andrews, St Andrews, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosa","family":"Morgan-Young","sequence":"additional","affiliation":[{"name":"University of St Andrews, St Andrews, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6623-4964","authenticated-orcid":false,"given":"Frank","family":"Sullivan","sequence":"additional","affiliation":[{"name":"University of St Andrews, St Andrews, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6074-6718","authenticated-orcid":false,"given":"Deirdre J","family":"Murphy","sequence":"additional","affiliation":[{"name":"Trinity College Dublin, Dublin, Ireland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jahan","family":"Albulushi","sequence":"additional","affiliation":[{"name":"Royal College of Surgeons in Ireland, Dublin, Ireland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Larkin","sequence":"additional","affiliation":[{"name":"Royal College of Surgeons in Ireland, Dublin, Ireland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2025,9,4]]},"reference":[{"key":"2025090408150958000_15.9.e094773.1","unstructured":"NHS Business Service Authority . Hormone Replacement Therapy - England April 2015 to June 2022, Available: https:\/\/www.nhsbsa.nhs.uk\/statistical-collections\/hormone-replacement-therapy-england\/hormone-replacement-therapy-england-april-2015-june-2022"},{"key":"2025090408150958000_15.9.e094773.2","unstructured":"Google Trends, Available: https:\/\/trends.google.com\/trends\/explore?date=today%205-y&geo=GB&q=HRT&hl=en-GB"},{"key":"2025090408150958000_15.9.e094773.3","unstructured":"Channel 4, Davina McColl, Sex, Mind and the Menopause, Available: https:\/\/trends.google.com\/trends\/explore?date=today%205-y&geo=GB&q=HRT&hl=en-GB"},{"key":"2025090408150958000_15.9.e094773.4","doi-asserted-by":"publisher","DOI":"10.1177\/07067437221082854"},{"key":"2025090408150958000_15.9.e094773.5","doi-asserted-by":"crossref","DOI":"10.2196\/17187","article-title":"Prevalence of Health Misinformation on Social Media: Systematic Review","volume":"23","author":"Suarez-Lledo","year":"2021","journal-title":"J Med Internet Res"},{"key":"2025090408150958000_15.9.e094773.6","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.0050095","article-title":"How do US journalists cover treatments, tests, products, and procedures? An evaluation of 500 stories","volume":"5","author":"Schwitzer","year":"2008","journal-title":"PLoS Med"},{"key":"2025090408150958000_15.9.e094773.7","doi-asserted-by":"publisher","DOI":"10.1136\/bmjebm-2022-112004"},{"key":"2025090408150958000_15.9.e094773.8","doi-asserted-by":"publisher","DOI":"10.3399\/bjgp22X721349"},{"key":"2025090408150958000_15.9.e094773.9","unstructured":"Statista . Active social network penetration in selected countries and territories as of January 2023, 2023. Available: https:\/\/www.statista.com\/statistics\/282846\/regular-social-networking-usage-penetration-worldwide-by-country\/, https:\/\/www.statista.com\/statistics\/1059219\/social-media-usage-uk-females\/"},{"key":"2025090408150958000_15.9.e094773.10","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1097\/GME.0000000000001713","article-title":"#Menopause on Instagram: a mixed-methods study","volume":"28","author":"Arseneau","year":"2021","journal-title":"Menopause"},{"key":"2025090408150958000_15.9.e094773.11","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1097\/GME.0000000000002012","article-title":"#Menopause: the menopause ontology project","volume":"29","author":"Trieu","year":"2022","journal-title":"Menopause"},{"key":"2025090408150958000_15.9.e094773.12","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.maturitas.2023.02.006","article-title":"Menopause and social media: Pros and cons for the general public","volume":"174","author":"Weiss","year":"2023","journal-title":"Maturitas"},{"key":"2025090408150958000_15.9.e094773.13","doi-asserted-by":"crossref","DOI":"10.1136\/bmjgh-2021-007648","article-title":"TikTok and public health: a proposed research agenda","volume":"6","author":"Zenone","year":"2021","journal-title":"BMJ Glob Health"},{"key":"2025090408150958000_15.9.e094773.14","doi-asserted-by":"crossref","DOI":"10.12688\/f1000research.52894.1","article-title":"Quality of information in news media reports about the effects of health interventions: Systematic review and meta-analyses","volume":"10","author":"Oxman","year":"2021","journal-title":"F1000Res"},{"key":"2025090408150958000_15.9.e094773.15","doi-asserted-by":"crossref","unstructured":"Orgad S , Rottenberg S . The Menopause Moment: The Rising Visibility of \u2018The Change\u2019 in UK news coverage to be published in European Journal of Cultural Studies (forthcoming), Available: https:\/\/eprints.lse.ac.uk\/118198\/1\/Orgad_and_Rottenberg_The_Menopause_Moment_EJC_February_2023_.pdf","DOI":"10.1177\/13675494231159562"},{"key":"2025090408150958000_15.9.e094773.16","doi-asserted-by":"publisher","DOI":"10.1177\/20533691231166543"},{"key":"2025090408150958000_15.9.e094773.17","unstructured":"Robert WA . Feminine forever. W.H. Allen \/ Virgin Books, 2022."},{"key":"2025090408150958000_15.9.e094773.18","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.327.7411.400"},{"key":"2025090408150958000_15.9.e094773.19","doi-asserted-by":"publisher","DOI":"10.1007\/s00228-007-0320-6"},{"key":"2025090408150958000_15.9.e094773.20","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2013.278040"},{"key":"2025090408150958000_15.9.e094773.21","article-title":"Long-term hormone therapy for perimenopausal and postmenopausal women","volume":"1","author":"Marjoribanks","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"key":"2025090408150958000_15.9.e094773.22","unstructured":"BMS Members . News alert. Joint BMS FFSRH RCGP RCOG SfE and RCN Women\u2019s Health Forum safety alert, 2023. Available: https:\/\/mailchi.mp\/8bc6ff4e32dd\/joint-bms-fsrh-rcgp-rcog-sfe-rcn-womens-health-forum-safety-alert?e=4ebb50b511"},{"key":"2025090408150958000_15.9.e094773.23","unstructured":"National Institute or Health and Care Excellence . Menopause. Scenario: Managing women with menopause, peri menopause, or premature ovarian insufficiency, Available: https:\/\/cks.nice.org.uk\/topics\/menopause\/management\/management-of-menopause-perimenopause-or-premature-ovarian-insufficiency\/"},{"key":"2025090408150958000_15.9.e094773.24","unstructured":"British National Formulary . Sex hormones, oestrogen and HRT, Available: https:\/\/bnf.nice.org.uk\/treatment-summaries\/sex-hormones\/#hormone-replacement-therapy"},{"key":"2025090408150958000_15.9.e094773.25","unstructured":"MHRA . Summary of HRT risknd benefits during current use and current use plus post-treatment from age of menopause up to age 69 years, per 1000 women with 5 years or 10 years use of HRT, Available: https:\/\/assets.publishing.service.gov.uk\/media\/5d680409e5274a1711fbe65a\/Table1.pdf"},{"key":"2025090408150958000_15.9.e094773.26","unstructured":"NICE . NICE issues first guideline on menopause to stop women suffering in silence, Available: https:\/\/thebms.org.uk\/wp-content\/uploads\/2015\/11\/NICE-Press-release.pdf"},{"key":"2025090408150958000_15.9.e094773.27","unstructured":"All-Party Parliamentary Group on Menopause Inquiry to assess the impacts of menopause and the case for policy reform Concluding report 12th October 2022, Available: https:\/\/menopause-appg.co.uk\/wp-content\/uploads\/2022\/10\/APPG-Menopause-Inquiry-Concluding-Report-12.10.22-1.pdf"},{"key":"2025090408150958000_15.9.e094773.28","unstructured":"National Institute for Health and Care Excellence . Menopause: Scenario: Managing women with perimenopause, or premature ovarian insufficiency, 2022. Available: https:\/\/cks.nice.org.uk\/topics\/menopause\/management\/management-of-menopause-perimenopause-or-premature-ovarian-insufficiency\/"},{"key":"2025090408150958000_15.9.e094773.29","unstructured":"British National Formularly . Hormone Replacement Therapy, Available: https:\/\/bnf.nice.org.uk\/treatment-summaries\/sex-hormones\/hormone-replacement-therapy"},{"key":"2025090408150958000_15.9.e094773.30","doi-asserted-by":"publisher","DOI":"10.1177\/1049732305276687"},{"key":"2025090408150958000_15.9.e094773.31","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1177\/01410768231181248","article-title":"Policies on doctors\u2019 declaration of interests in medical organisations: a thematic analysis","volume":"116","author":"Tzortziou Brown","year":"2023","journal-title":"J R Soc Med"},{"key":"2025090408150958000_15.9.e094773.32","unstructured":"Disclosure UK . Association of the British Pharmaceutical Industry, Available: https:\/\/www.abpi.org.uk\/reputation\/disclosure-uk\/"},{"key":"2025090408150958000_15.9.e094773.33","unstructured":"The Association of UK Dieticians . What are dietitians, nutritionists, and nutritional therapists, Available: https:\/\/www.bda.uk.com\/about-dietetics\/what-is-dietitian\/dietitian-or-nutritionist.html#:~:text=of%20supplementary%20nutrients.-,Is%20their%20title%20protected%20by%20law%3F,Nutritionist%20or%20a%20Diet%20Expert"},{"key":"2025090408150958000_15.9.e094773.34","unstructured":"National Institute for Health and Care Excellence . When should I suspect a diagnosis of menopause or peri menopause?, Available: https:\/\/cks.nice.org.uk\/topics\/menopause\/diagnosis\/diagnosis-of-menopause-perimenopause\/#:~:text=Do%20not%20routinely%20use%20blood,years%2C%20with%20typical%20menopausal%20symptoms"},{"key":"2025090408150958000_15.9.e094773.35","first-page":"477","article-title":"Women\u2019s decisions about whether or not to take hormone replacement therapy: influence of social and medical factors","volume":"45","author":"Griffiths","year":"1995","journal-title":"Br J Gen Pract"},{"key":"2025090408150958000_15.9.e094773.36","unstructured":"NICE . Shared Decision Making, Available: https:\/\/www.nice.org.uk\/about\/what-we-do\/our-programmes\/nice-guidance\/nice-guidelines\/shared-decision-making"},{"key":"2025090408150958000_15.9.e094773.37","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1001\/jamainternmed.2016.8254","article-title":"Clinicians\u2019 Expectations of the Benefits and Harms of Treatments, Screening, and Tests: A Systematic Review","volume":"177","author":"Hoffmann","year":"2017","journal-title":"JAMA Intern Med"},{"key":"2025090408150958000_15.9.e094773.38","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1001\/jamainternmed.2014.6016","article-title":"Patients\u2019 expectations of the benefits and harms of treatments, screening, and tests: a systematic review","volume":"175","author":"Hoffmann","year":"2015","journal-title":"JAMA Intern Med"},{"key":"2025090408150958000_15.9.e094773.39","doi-asserted-by":"publisher","DOI":"10.1111\/1467-9566.00360"},{"key":"2025090408150958000_15.9.e094773.40","doi-asserted-by":"publisher","DOI":"10.1136\/bmjsrh-2023-202099"},{"key":"2025090408150958000_15.9.e094773.41","unstructured":"The Times . Don\u2019t just stick women on HRT during menopause, says health chief, Available: https:\/\/www.thetimes.com\/uk\/healthcare\/article\/dont-automatically-prescribe-hrt-for-menopause-says-womens-health-chief-77cb5bpts"},{"key":"2025090408150958000_15.9.e094773.42","unstructured":"British Menopause Society . BMS comment on Channel 4 programme: Davina McCall, Sex, Myths and the Menopause, Available: https:\/\/thebms.org.uk\/2022\/05\/bms-comment-on-channel-4-programme-davina-mccall-sex-myths-and-the-menopause\/?_gl=1*1nt0wui*_up*MQ..*_ga*MTQyODU3MTY3NS4xNzIzMTI3MTM1*_ga_C6WZGMG880*MTcyMzEyNzEzNC4xLjEuMTcyMzEyNzQyOC4wLjAuMA"},{"key":"2025090408150958000_15.9.e094773.43","unstructured":"NICE . Menopause:Identification and management, Available: https:\/\/www.nice.org.uk\/guidance\/ng23\/chapter\/Recommendations#managing-symptoms-associated-with-menopause-in-people-aged-40-or-over"}],"container-title":["BMJ Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjopen-2024-094773","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,4]],"date-time":"2025-09-04T15:21:49Z","timestamp":1756999309000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopen.bmj.com\/lookup\/doi\/10.1136\/bmjopen-2024-094773"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":43,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2025,9,4]]},"published-print":{"date-parts":[[2025,9]]}},"alternative-id":["10.1136\/bmjopen-2024-094773"],"URL":"https:\/\/doi.org\/10.1136\/bmjopen-2024-094773","relation":{"has-part":[{"id-type":"doi","id":"https:\/\/doi.org\/10.1136\/bmjopen-2024-094773.supp1","asserted-by":"subject"},{"id-type":"doi","id":"https:\/\/doi.org\/10.1136\/bmjopen-2024-094773.supp2","asserted-by":"subject"},{"id-type":"doi","id":"https:\/\/doi.org\/10.1136\/bmjopen-2024-094773.supp3","asserted-by":"subject"},{"id-type":"doi","id":"https:\/\/doi.org\/10.1136\/bmjopen-2024-094773.supp4","asserted-by":"subject"}]},"ISSN":["2044-6055","2044-6055"],"issn-type":[{"value":"2044-6055","type":"print"},{"value":"2044-6055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9]]}}}